Study of Phosphate Levels in Patients With Chronic Kidney Disease
Public ClinicalTrials.gov record NCT00824460. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-label, Randomised, Active Controlled Multi-center Phase II Dose Finding Study to Evaluate the Ability of PA21 to Lower Serum Phosphate Levels and the Tolerability in Patients With Chronic Kidney Disease on Maintenance Hemodialysis
Study identification
- NCT ID
- NCT00824460
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Vifor Pharma
- Industry
- Enrollment
- 154 participants
Conditions and interventions
Conditions
Interventions
- 1.25 g PA21 (250 mg iron) Drug
- 5.0 g PA21 (1,000 mg iron) Drug
- 7.5 g PA21 (1,500 mg iron) Drug
- 10.0 g PA21 (2,000 mg iron) Drug
- 12.5 g PA21 (2,500 mg iron) Drug
- Sevelamer hydrochloride Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2008
- Primary completion
- Sep 30, 2009
- Completion
- Feb 28, 2010
- Last update posted
- Mar 31, 2014
2008 – 2010
United States locations
- U.S. sites
- 9
- U.S. states
- 7
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Western Nephrology & Metabolic Disease | Arvada | Colorado | 80002 | — |
| Complete Renal Care | Denver | Colorado | 80220 | — |
| Pines Clinical Research | Pembroke Pines | Florida | 33028 | — |
| University of Kansas Medical Center | Kansas City | Kansas | 66160 | — |
| Nephrology Associates | Fresh Meadows | New York | 11365 | — |
| University Hospitals / Case Medical Center | Cleveland | Ohio | 44106 | — |
| Southeast Renal Research Institute | Chattanooga | Tennessee | 37404 | — |
| Nephrology Associates | Nashville | Tennessee | 37205 | — |
| Southwest Houston Research | Houston | Texas | 77099 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 51 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00824460, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 31, 2014 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00824460 live on ClinicalTrials.gov.